AOD-9604
AdjacentResearch ongoing — see primary literature for current evidence.
Tesamorelin
Longevity SupportVisceral adiposity reduction; GH axis restoration; cardiovascular risk profile improvement
Clinical Decision Framework
When evaluating AOD-9604 versus Tesamorelin for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize AOD-9604:
Select AOD-9604 when the primary clinical objective aligns with its core mechanism: modified c-terminal fragment of human growth hormone that stimulates lipolysis via beta-3 adrenergic receptors without gh side effects.. This is particularly relevant for protocols focused on targeted fat metabolism and body composition improvement without gh-related side effects..
When to prioritize Tesamorelin:
Conversely, Tesamorelin is the superior choice when targeting ghrh analog that stimulates pituitary gh release, leading to igf-1 elevation and visceral fat reduction., making it the preferred agent for visceral fat reduction and gh stimulation..
Begin Your Age Reversal Protocol for AOD-9604 or Tesamorelin
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing